Work

Daclatasvir plus Sofosbuvir plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients with HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis

Year: 2016

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(16)01469-0

Authors: C. Hezode, G. Dore, S. Pianko, S. Pol, K. Stuart, A. Thompson, E. Tse, R. Bhore, M.J. Jimenez-Exposito

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2522311562

FWCI: 0.482

Cites:

Cited by: 2

Related to: 10